Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds
Feb 15, 2021 10:00 am | Steve Bryson PhD
Off-label use of the inhaled antibiotic tobramycin lowered sputum production, and eased shortness of breath, and cough in people with bronchiectasis, a small real-world study found. Although there was no significant improvement in lung function, the antibiotic eliminated almost half of the reported Pseudomonas aeruginosa infections and led to fewer hospitalizations. Further studies are necessary […]
The post Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds appeared first on Bronchiectasis News Today.